Total submissions: 25
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000075123 | SCV000106114 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | MAF >1% |
Invitae | RCV001081259 | SCV000166240 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000121360 | SCV000170294 | benign | not specified | 2013-10-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000129936 | SCV000184754 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000121360 | SCV000303143 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000662558 | SCV000443333 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Laboratory for Molecular Medicine, |
RCV000121360 | SCV000539632 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC: 3.9% East Asian chromosomes |
Genetic Services Laboratory, |
RCV000121360 | SCV000595802 | benign | not specified | 2019-02-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000129936 | SCV000684719 | benign | Hereditary cancer-predisposing syndrome | 2015-04-07 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000662558 | SCV000785156 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2017-05-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000755644 | SCV000883043 | likely benign | Mismatch repair cancer syndrome 1; Muir-Torré syndrome; Colorectal cancer, hereditary nonpolyposis, type 2 | 2022-05-10 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000129936 | SCV002528627 | benign | Hereditary cancer-predisposing syndrome | 2020-05-27 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000121360 | SCV002760286 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149604 | SCV003838210 | benign | Breast and/or ovarian cancer | 2022-02-08 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000662558 | SCV004015887 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000034537 | SCV004185049 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | MLH1: BS1, BS2 |
Biesecker Lab/Clinical Genomics Section, |
RCV000034537 | SCV000043322 | no known pathogenicity | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Benign. |
ITMI | RCV000121360 | SCV000085541 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Pathway Genomics | RCV000144609 | SCV000189936 | benign | Lynch syndrome 1 | 2014-07-24 | no assertion criteria provided | clinical testing | |
Database of Curated Mutations |
RCV000437810 | SCV000504967 | likely pathogenic | Lung adenocarcinoma | 2015-07-14 | no assertion criteria provided | literature only | |
Database of Curated Mutations |
RCV000420168 | SCV000504968 | likely pathogenic | Gastric adenocarcinoma | 2015-07-14 | no assertion criteria provided | literature only | |
Department of Pathology and Laboratory Medicine, |
RCV001353661 | SCV000592396 | benign | Bile duct cancer | no assertion criteria provided | clinical testing | The MLH1 p.Val384Asp variant was identified in the literature and by our laboratory. It was identified in 104 of 3286 proband chromosomes (allele frequency 0.03) with different cancer types including colon, pancreatic and lung; and was identified in 53 of 2818 race-matched control chromosomes (allele frequency 0.03), increasing the likelihood that this is a benign variant in certain populations of origin (Chao 2008, Fan 2007, Kim 2010, Kim 2004, Ku 2002, Li 2005 , Lee 2005, Mei 2006, Ohsawa 2009, Shi 2003, Wang 2007, Wang 1998, Yan 2008 , Yap 2009, Yuan 2004,). The variant was also identified in dbSNP (ID: rs63750447) with a minor allele frequency of 0.009 (1000 Genomes Project), COSMIC, “Mismatch Repair Genes Variant Database”, “InSiGHT Colon Cancer Database”, “Zhejiang Colon Cancer Database”, ClinVar database, and UMD (2X as a neutral variant). The variant was identified in co-occurrence with pathogenic MLH1 variants by Lee (2005) (c.1459C > T (p.Arg487X)), by our laboratory (c.453+1G>T, r.spl?), and in a sample submitted to UMD (c.453+1G>T), increasing the likelihood that the p.Val384Asp variant does not have clinical importance. In addition, based on a personal communication with the Pathology Department of the University of Hong Kong, sequencing on normal population DNA from their locality (108 normal blood DNA), this variant was found in 7 individuals and was regarded as a non-pathogenic variant. Furthermore, the variant was classified as benign by 4 submitters to the ClinVar database: InSiGHT (reviewed by expert panel), GeneDX, Ambry Genetics, and the Biesecker Laboratory – ClinSeq Project. In summary, based on the above information, this variant meets our laboratory's criteria to be classified as benign. | |
Genome Diagnostics Laboratory, |
RCV000121360 | SCV001977734 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000121360 | SCV001979021 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000121360 | SCV002036468 | benign | not specified | no assertion criteria provided | clinical testing |